| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $455,972 ) |
| | 2025 | 2025 | MMJ LABS LLC | 195 ARIZONA AVE NE | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA058952 | Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT) | 001 | 2 | NIH | 1/9/2025 | $455,972 |
| | 2025 | 2023 | MMJ LABS LLC | 195 ARIZONA AVE NE | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA058952 | Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT) | 000 | 1 | NIH | 1/7/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | MMJ LABS LLC | 195 ARIZONA AVE NE | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA058952 | Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT) | 000 | 1 | NIH | 11/1/2023 | $0 |
| | 2024 | 2021 | MMJ LABS LLC | 195 ARIZONA AVE NE | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 000 | 3 | NIH | 3/18/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $248,510 ) |
| | 2023 | 2023 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 000 | 3 | NIH | 2/14/2023 | $89,400 |
| | 2023 | 2023 | MMJ LABS LLC | 195 ARIZONA AVE NE | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA058952 | Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT) | 000 | 1 | NIH | 8/30/2023 | $159,110 |
|
| Issue Date FY: 2021 ( Subtotal = $688,522 ) |
| | 2021 | 2021 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 000 | 3 | NIH | 3/17/2021 | $688,522 |
|
| Issue Date FY: 2020 ( Subtotal = $811,478 ) |
| | 2020 | 2020 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 001 | 2 | NIH | 3/31/2020 | $811,478 |
| | 2020 | 2019 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 000 | 1 | NIH | 1/17/2020 | $0 |
| | 2020 | 2019 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 002 | 1 | NIH | 8/24/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $221,959 ) |
| | 2019 | 2019 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 001 | 1 | NIH | 9/27/2019 | $0 |
| | 2019 | 2019 | MMJ LABS, LLC | 195 ARIZONA AVE LW08 | ATLANTA | GA | 30307-2246 | FULTON | USA | R44DA049631 | Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain. | 000 | 1 | NIH | 9/18/2019 | $221,959 |
|
| Issue Date FY: 2010 ( Subtotal = $468,634 ) |
| | 2010 | 2010 | MMJ LABS LLC | 322 SUTHERLAND PLACE | ATLANTA | GA | 30307 | FULTON | USA | R44HD056647 | RELIEVING PEDIATRIC IMMUNIZATION PAIN USING A REUSABLE PERSONAL DEVICE | 001 | 3 | NIH | 8/30/2010 | $468,634 |
| | 2010 | 2009 | MMJ LABS LLC | 322 SUTHERLAND PLACE | ATLANTA | GA | 30307 | FULTON | USA | R44HD056647 | RELIEVING PEDIATRIC IMMUNIZATION PAIN USING A REUSABLE PERSONAL DEVICE | 000 | 2 | NIH | 2/8/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $593,254 ) |
| | 2009 | 2009 | MMJ LABS LLC | 322 SUTHERLAND PLACE | ATLANTA | GA | 30307 | FULTON | USA | R44HD056647 | RELIEVING PEDIATRIC IMMUNIZATION PAIN USING A REUSABLE PERSONAL DEVICE | 002 | 2 | NIH | 9/4/2009 | $469,334 |
| | 2009 | 2009 | MMJ LABS LLC | 322 SUTHERLAND PLACE | ATLANTA | GA | 30307 | FULTON | USA | R44HD056647 | RELIEVING PEDIATRIC IMMUNIZATION PAIN USING A REUSABLE PERSONAL DEVICE | 001 | 1 | NIH | 9/4/2009 | $0 |
| | 2009 | 2009 | MMJ LABS LLC | 322 SUTHERLAND PLACE | ATLANTA | GA | 30307 | FULTON | USA | R44HD056647 | RELIEVING PEDIATRIC IMMUNIZATION PAIN USING A REUSABLE PERSONAL DEVICE | 000 | 1 | NIH | 2/11/2009 | $123,920 |
|
|
